You are here: All Products  > Simcere Announces Positive Data from Phase III Trial of Dual-Drug Oral Therapy for Stroke

Simcere Announces Positive Data from Phase III Trial of Dual-Drug Oral Therapy for Stroke

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products